mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.02 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.02 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
GDC-0941 |
CTRPv2 |
pan-cancer |
AAC |
0.082 |
0.02 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
0.076 |
0.03 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.03 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.03 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.03 |
mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
0.099 |
0.03 |